Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Feb;22(2):207–222. doi: 10.1177/1933719114537712

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2014

PMC Copyright notice

Figure 6. — Fetal bovine serum (FBS) restriction and bovine serum albumin (BSA) supplementation affect the expression of key myogenic proteins by cultured e19 fetal rat lung lipofibroblasts (LIFs). In e19 LIFs, FBS restriction increased the expression of fibronectin, calponin, β-catenin, and LEF-1 (A); BSA supplementation blocked these effects (B-E). After a 24-hour incubation period, FBS-restricted cells demonstrated increased β-catenin levels along with its increased nuclear translocation, increased LEF-1 levels, and decreased lipid content; all of these effects were blocked by BSA supplementation (F). * = P < .05 versus 10% FBS and # = P < .05 versus 0% FBS; N = 4. e19 indicates embryonic day 19; LEF-1, lymphoid enhancer-binding factor 1.

Figure 6. — Fetal bovine serum (FBS) restriction and bovine serum albumin (BSA) supplementation affect the expression of key myogenic proteins by cultured e19 fetal rat lung lipofibroblasts (LIFs). In e19 LIFs, FBS restriction increased the expression of fibronectin, calponin, β-catenin, and LEF-1 (A); BSA supplementation blocked these effects (B-E). After a 24-hour incubation period, FBS-restricted cells demonstrated increased β-catenin levels along with its increased nuclear translocation, increased LEF-1 levels, and decreased lipid content; all of these effects were blocked by BSA supplementation (F). * = P < .05 versus 10% FBS and # = P < .05 versus 0% FBS; N = 4. e19 indicates embryonic day 19; LEF-1, lymphoid enhancer-binding factor 1.